You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for NDC 46122-0615


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 46122-0615

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

46122-0615 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 46122-0615

Understanding the NDC Number

To begin with, it's crucial to understand what the National Drug Code (NDC) represents. The NDC 46122-0615 is a unique 10-digit number that identifies a specific drug product. This number is divided into three segments: the labeler code, the product code, and the package code.

  • Labeler Code: The first segment (46122) is assigned by the FDA and identifies the firm that manufactures or distributes the drug.
  • Product Code: The second segment (06) identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment (15) identifies the package size and type[1][4].

Market Context

Drug Price Inflation

The pharmaceutical market is experiencing significant price inflation, particularly driven by specialty pharmaceuticals. According to Vizient's Pharmacy Market Outlook, the overall drug price inflation rate for 2025 is projected to be around 3.8%, with specialty pharmaceuticals being a major contributor to this increase[3].

Specialty Pharmaceuticals

Specialty pharmaceuticals, which include drugs for complex or chronic conditions such as cancer, infectious diseases, and autoimmune diseases, are a significant factor in the rising costs. For instance, weight loss drugs like semaglutide have seen a 77% increase in spend since the summer 2023 Outlook. Gene therapies, another rapidly growing field, are also expected to impact provider budgets substantially[3].

Specific Drug Analysis

Identifying the Drug

To analyze the market and price projections for the drug with NDC 46122-0615, we need to identify the specific drug product. This involves searching the FDA's National Drug Code Directory or other pharmaceutical databases.

Example: Eliquis

For illustrative purposes, let's consider a similar drug like Eliquis (apixaban), which is a blood thinner. Eliquis is listed in the NDC directory with various NDC numbers corresponding to different package sizes and formulations. If the drug with NDC 46122-0615 is similar in nature (e.g., a cardiovascular or anticoagulant medication), we can draw some parallels.

Price Projections

General Trends

Given the current market trends, here are some key points to consider for price projections:

  • Specialty Drugs: If the drug falls under the category of specialty pharmaceuticals, it is likely to see a higher price increase. Vizient projects a 4.18% increase for specialty medications[3].
  • Gene Therapies: While not directly applicable unless the drug is a gene therapy, these treatments are expected to have a significant impact on costs, with some therapies costing over $2 million per dose[3].

Medicare Negotiations

For drugs that are widely used by Medicare beneficiaries, the Medicare Drug Price Negotiation Program could impact prices. For example, drugs like Eliquis, which are selected for negotiation, will see negotiated prices that could result in discounts ranging from 38% to 79% compared to list prices[5].

Impact of Market Factors

Drug Shortages and Supply Chain

Drug shortages and supply chain issues can also affect pricing. Hospitals and healthcare providers have faced challenges in 2023 due to drug shortages and rising costs, which can lead to price volatility[3].

Biosimilars and Generics

The introduction of biosimilars and generics can reduce prices for certain drugs. However, for unique or patented drugs, this may not be a factor. For instance, biosimilar adalimumab products are expected to gain market share, potentially reducing the dominance and prices of originator products like Humira[3].

Key Takeaways

  • NDC Identification: The NDC number is crucial for identifying and tracking drug products.
  • Market Trends: Specialty pharmaceuticals and gene therapies are driving significant price increases.
  • Medicare Negotiations: Negotiated prices under Medicare programs can lead to substantial discounts.
  • Supply Chain and Shortages: These can cause price volatility and affect market stability.
  • Biosimilars and Generics: These can reduce prices for certain drugs but may not impact patented or unique medications.

FAQs

  1. What is the National Drug Code (NDC)?

    • The NDC is a unique 10-digit number that identifies a specific drug product, including the labeler, product, and package details.
  2. How are drug prices projected to change in 2025?

    • According to Vizient, the overall drug price inflation rate for 2025 is projected to be around 3.8%, driven largely by specialty pharmaceuticals.
  3. What impact do gene therapies have on drug costs?

    • Gene therapies can significantly increase costs, with some treatments exceeding $2 million per dose, and are expected to have a major impact on provider budgets.
  4. How do Medicare negotiations affect drug prices?

    • Medicare negotiations can result in substantial discounts, ranging from 38% to 79% compared to list prices, for selected high-expenditure drugs.
  5. What role do biosimilars play in reducing drug costs?

    • Biosimilars can reduce prices by increasing competition, especially for drugs like adalimumab, where biosimilar products are gaining market share.

Sources

  1. FDA - National Drug Code Directory
  2. Vizient - Pharmacy Market Outlook
  3. Vizient - Specialty Pharmaceuticals
  4. FDA - National Drug Code Database Background Information
  5. HHS - Medicare Drug Price Negotiation Program

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.